BAUSSS biomarker improves melanoma survival risk assessment
We encourage clinicians to download and print in colour this single-page BAUSSS mortality prediction tool, laminate it, and use it face to face with the patient in consultations. Not only will the patient be able to recognize his/her long-term prognosis but will also be able to see how their tumour severity compares with others.
Authors
- Howard K. Steinman (ORCID: https://orcid.org/0000-0002-0333-2882)
- Christos C. Zouboulis (ORCID: https://orcid.org/0000-0003-1646-2608)
- Caterina Longo (ORCID: https://orcid.org/0000-0002-8218-3896)
- C Popescu (ORCID: https://orcid.org/0000-0003-2986-6935)
- Anthony Dixon (ORCID: https://orcid.org/0000-0001-8071-7199)
- Stuart Anderson (ORCID: https://orcid.org/0000-0002-4998-8713)
- Alexander Nirenberg (ORCID: https://orcid.org/0000-0001-8645-5388)
- Michael J Sladden (ORCID: https://orcid.org/0000-0001-7281-2444)
- Joseph Thomas (ORCID: https://orcid.org/0000-0003-0950-5235)
Institutions
- University of Modena and Reggio Emilia (IT)
- University of Tasmania (AU)
- Campbell University (US)
- Carol Davila University of Medicine and Pharmacy (RO)
- Azienda Sanitaria Unità Locale di Reggio Emilia (IT)
- Städtisches Klinikum Dessau (DE)
- Royal Marsden Hospital (GB)
- Medizinische Hochschule Brandenburg Theodor Fontane (DE)
- Australasian College for Emergency Medicine (AU)
Publication Details
- Journal
- Journal of the European Academy of Dermatology and Venereology
- Published
- 2024-08-31
- DOI
- https://doi.org/10.1111/jdv.20292
- Citations
- 4
- Primary Topic
- Cutaneous Melanoma Detection and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.13